ID

44516

Description

The Effect of Postoperative Interferon- Alpha Treatment in Low miR-26 Expression Patients With HCC; ODM derived from: https://clinicaltrials.gov/show/NCT01681446

Link

https://clinicaltrials.gov/show/NCT01681446

Keywords

Versions (2)
  1. 2/20/20 2/20/20 -
  2. 9/27/21 9/27/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 27, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatocellular Carcinoma NCT01681446

English

Eligibility Hepatocellular Carcinoma NCT01681446

1 forms  
Criteria
Description

Criteria

1. signed informed consent;
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
2. aged ≥ 18 years and ≤ 75 years old, male or female；
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
3. patients with low mir-26 expression(confirmed by rt-pcr) underwent a curative resection of hcc;
Description

Other Coding | Excision Curative Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C3846158
UMLS CUI [2,1]
C0728940
UMLS CUI [2,2]
C1276305
UMLS CUI [2,3]
C2239176
4. the tumor characteristics must meet the following:
Description

Tumor Characteristics

Data type

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1521970
1. tumor diameter is between 3 to 8 centimeters,and the number of tumor is less tnan 3
Description

Tumor Diameter | Tumor Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1301886
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C1265611
2. no thrombosis is detected in the main branches of the portal vein, hepatic vein and bile duct
Description

Portal vein thrombosis Absent | Hepatic Vein Thrombosis Absent | Bile duct Thrombosis Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0155773
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0019154
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0005400
UMLS CUI [3,2]
C0040053
UMLS CUI [3,3]
C0332197
3. no extrahepatic and lymphnode metastasis
Description

Neoplasm Metastasis Extrahepatic Absent | Secondary malignant neoplasm of lymph node Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1517058
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0686619
UMLS CUI [2,2]
C0332197
perioperative period exclusion criteria:
Description

Perioperative Period Exclusion Criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C2712230
UMLS CUI [1,2]
C0680251
1. concomitant malignant primary tumor(s) in other systems is/are present;
Description

Primary tumor System Other

Data type

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0460002
UMLS CUI [1,3]
C0205394
2. the subject receives any previous systemic anti-hcc therapy prior to the resection surgery (except the resection surgery), such as liver transplantation, intervention, ablation, radiotherapy, chemotherapy, molecular targeted therapy or other anti-hcc therapy;
Description

Systemic therapy Liver carcinoma | Status pre- Excision | Transplantation of liver | Intervention | Ablation | Therapeutic radiology procedure | Chemotherapy | Molecular Targeted Therapy | Therapy Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C2239176
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C0728940
UMLS CUI [3]
C0023911
UMLS CUI [4]
C0184661
UMLS CUI [5]
C0547070
UMLS CUI [6]
C1522449
UMLS CUI [7]
C0392920
UMLS CUI [8]
C2699893
UMLS CUI [9,1]
C0087111
UMLS CUI [9,2]
C2239176
3. the subject takes other study/investigational drugs during this study;
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
4. the subject has cerebrovascular accident, renal insufficiency, depression, hyperthyreosis, hypothyroidism or other severe uncontrolled diseases;
Description

Cerebrovascular accident | Renal Insufficiency | Depressive disorder | Hyperthyroidism | Hypothyroidism | Disease Severe Uncontrolled

Data type

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C1565489
UMLS CUI [3]
C0011581
UMLS CUI [4]
C0020550
UMLS CUI [5]
C0020676
UMLS CUI [6,1]
C0012634
UMLS CUI [6,2]
C0205082
UMLS CUI [6,3]
C0205318
5. the subject has a history of study drug or similar drug allergy.
Description

Hypersensitivity Investigational New Drugs | Drug Allergy Similar

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C2348205
baseline (post-surgeryday 25 ± 5) inclusion criteria:
Description

Postoperative Period Inclusion criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C0032790
UMLS CUI [1,2]
C1512693
1. baseline (post-resection) blood routine examination shows that the number of leukocyte>2.5*10^9/l and platelet count>40*10^9/l;
Description

Status post Excision | Blood Examination | White Blood Cell Count procedure | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0728940
UMLS CUI [2]
C3826648
UMLS CUI [3]
C0023508
UMLS CUI [4]
C0032181
2. child-pugh score of class a at baseline.
Description

Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1]
C4050412
baseline (post-surgeryday 25 ± 5) exclusion criteria:
Description

Postoperative Period Exclusion Criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C0032790
UMLS CUI [1,2]
C0680251
1. concomitant malignant primary tumor(s) in other systems is/are present;
Description

Primary tumor System Other

Data type

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0460002
UMLS CUI [1,3]
C0205394
2. the subject takes other study/investigational drugs within 4 weeks prior to randomization;
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
3. the baseline examination indicates that infection, bleeding, bile leakage, or other postoperative complications are present;
Description

Communicable Disease | Hemorrhage | Leakage of bile | Postoperative Complications

Data type

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0019080
UMLS CUI [3]
C0400997
UMLS CUI [4]
C0032787
4. the baseline examination suggests the presence of tumor metastasis;
Description

Suggestive of Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1,1]
C0332299
UMLS CUI [1,2]
C0027627
5. the subject has cerebrovascular accident, renal insufficiency, depression, hyperthyreosis, hypothyroidism or other severe uncontrolled diseases;
Description

Cerebrovascular accident | Renal Insufficiency | Depressive disorder | Hyperthyroidism | Hypothyroidism | Disease Severe Uncontrolled

Data type

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C1565489
UMLS CUI [3]
C0011581
UMLS CUI [4]
C0020550
UMLS CUI [5]
C0020676
UMLS CUI [6,1]
C0012634
UMLS CUI [6,2]
C0205082
UMLS CUI [6,3]
C0205318
6. the subject has a history of investigational drug or similar drug allergy;
Description

Hypersensitivity Investigational New Drugs | Drug Allergy Similar

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C2348205
7. the subject is pregnant, lactating, or urine pregnancy test result is positive.
Description

Pregnancy | Breast Feeding | Urine pregnancy test positive

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0430059
Back to the top of the page

Similar models

Eligibility Hepatocellular Carcinoma NCT01681446

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Informed Consent
Item
1. signed informed consent;
boolean
C0021430 (UMLS CUI [1])
Age
Item
2. aged ≥ 18 years and ≤ 75 years old, male or female；
boolean
C0001779 (UMLS CUI [1])
Other Coding | Excision Curative Liver carcinoma
Item
3. patients with low mir-26 expression(confirmed by rt-pcr) underwent a curative resection of hcc;
boolean
C3846158 (UMLS CUI [1])
C0728940 (UMLS CUI [2,1])
C1276305 (UMLS CUI [2,2])
C2239176 (UMLS CUI [2,3])
Tumor Characteristics
Item
4. the tumor characteristics must meet the following:
boolean
C0027651 (UMLS CUI [1,1])
C1521970 (UMLS CUI [1,2])
Tumor Diameter | Tumor Quantity
Item
1. tumor diameter is between 3 to 8 centimeters,and the number of tumor is less tnan 3
boolean
C0027651 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Portal vein thrombosis Absent | Hepatic Vein Thrombosis Absent | Bile duct Thrombosis Absent
Item
2. no thrombosis is detected in the main branches of the portal vein, hepatic vein and bile duct
boolean
C0155773 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0019154 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0005400 (UMLS CUI [3,1])
C0040053 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
Neoplasm Metastasis Extrahepatic Absent | Secondary malignant neoplasm of lymph node Absent
Item
3. no extrahepatic and lymphnode metastasis
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0686619 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Perioperative Period Exclusion Criteria
Item
perioperative period exclusion criteria:
boolean
C2712230 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Primary tumor System Other
Item
1. concomitant malignant primary tumor(s) in other systems is/are present;
boolean
C0677930 (UMLS CUI [1,1])
C0460002 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Systemic therapy Liver carcinoma | Status pre- Excision | Transplantation of liver | Intervention | Ablation | Therapeutic radiology procedure | Chemotherapy | Molecular Targeted Therapy | Therapy Liver carcinoma
Item
2. the subject receives any previous systemic anti-hcc therapy prior to the resection surgery (except the resection surgery), such as liver transplantation, intervention, ablation, radiotherapy, chemotherapy, molecular targeted therapy or other anti-hcc therapy;
boolean
C1515119 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
C0332152 (UMLS CUI [2,1])
C0728940 (UMLS CUI [2,2])
C0023911 (UMLS CUI [3])
C0184661 (UMLS CUI [4])
C0547070 (UMLS CUI [5])
C1522449 (UMLS CUI [6])
C0392920 (UMLS CUI [7])
C2699893 (UMLS CUI [8])
C0087111 (UMLS CUI [9,1])
C2239176 (UMLS CUI [9,2])
Investigational New Drugs
Item
3. the subject takes other study/investigational drugs during this study;
boolean
C0013230 (UMLS CUI [1])
Cerebrovascular accident | Renal Insufficiency | Depressive disorder | Hyperthyroidism | Hypothyroidism | Disease Severe Uncontrolled
Item
4. the subject has cerebrovascular accident, renal insufficiency, depression, hyperthyreosis, hypothyroidism or other severe uncontrolled diseases;
boolean
C0038454 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
C0011581 (UMLS CUI [3])
C0020550 (UMLS CUI [4])
C0020676 (UMLS CUI [5])
C0012634 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0205318 (UMLS CUI [6,3])
Hypersensitivity Investigational New Drugs | Drug Allergy Similar
Item
5. the subject has a history of study drug or similar drug allergy.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013182 (UMLS CUI [2,1])
C2348205 (UMLS CUI [2,2])
Postoperative Period Inclusion criteria
Item
baseline (post-surgeryday 25 ± 5) inclusion criteria:
boolean
C0032790 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
Status post Excision | Blood Examination | White Blood Cell Count procedure | Platelet Count measurement
Item
1. baseline (post-resection) blood routine examination shows that the number of leukocyte>2.5*10^9/l and platelet count>40*10^9/l;
boolean
C0231290 (UMLS CUI [1,1])
C0728940 (UMLS CUI [1,2])
C3826648 (UMLS CUI [2])
C0023508 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
Child-Pugh Classification
Item
2. child-pugh score of class a at baseline.
boolean
C4050412 (UMLS CUI [1])
Postoperative Period Exclusion Criteria
Item
baseline (post-surgeryday 25 ± 5) exclusion criteria:
boolean
C0032790 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Primary tumor System Other
Item
1. concomitant malignant primary tumor(s) in other systems is/are present;
boolean
C0677930 (UMLS CUI [1,1])
C0460002 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Investigational New Drugs
Item
2. the subject takes other study/investigational drugs within 4 weeks prior to randomization;
boolean
C0013230 (UMLS CUI [1])
Communicable Disease | Hemorrhage | Leakage of bile | Postoperative Complications
Item
3. the baseline examination indicates that infection, bleeding, bile leakage, or other postoperative complications are present;
boolean
C0009450 (UMLS CUI [1])
C0019080 (UMLS CUI [2])
C0400997 (UMLS CUI [3])
C0032787 (UMLS CUI [4])
Suggestive of Neoplasm Metastasis
Item
4. the baseline examination suggests the presence of tumor metastasis;
boolean
C0332299 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Cerebrovascular accident | Renal Insufficiency | Depressive disorder | Hyperthyroidism | Hypothyroidism | Disease Severe Uncontrolled
Item
5. the subject has cerebrovascular accident, renal insufficiency, depression, hyperthyreosis, hypothyroidism or other severe uncontrolled diseases;
boolean
C0038454 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
C0011581 (UMLS CUI [3])
C0020550 (UMLS CUI [4])
C0020676 (UMLS CUI [5])
C0012634 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0205318 (UMLS CUI [6,3])
Hypersensitivity Investigational New Drugs | Drug Allergy Similar
Item
6. the subject has a history of investigational drug or similar drug allergy;
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013182 (UMLS CUI [2,1])
C2348205 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Urine pregnancy test positive
Item
7. the subject is pregnant, lactating, or urine pregnancy test result is positive.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0430059 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial